References
- British Committee for Standards in Haematology, Milkins C, Berryman J, Cantwell C, et al. Guidelines for pre-transfusion compatibility procedures in blood transfusion laboratories. British Committee for Standards in Haematology. Transfus Med 2013;23:3–35.
- Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8.
- Technical manual, 20th ed. Bethesda, MD: AABB, 2020.
- Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978;18:137–41.
- Cordle DG, Strauss RG, Snyder EL, Floss AM. Safety and cost-containment data that advocate abbreviated pretransfusion testing. Am J Clin Pathol 1990;94:428–31.
- Heddle NM, O’Hoski P, Singer J, McBride JA, Ali MA, Kelton JG. A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol 1992;81:579–84.
- The Drug and Cosmetics Act, 1940, and the Drug and Cosmetics Rules, 1945, as amended up to 30th June, 2005. Schedule F. Part XIIB. Central Drugs Standard Control Organization. Director General of Health Services. Ministry of Health and Family Welfare. Government of India; 268–288. Available from http://www.cdsco.nic.in/writereaddata/drugs&cosmeticact.pdf. Accessed 22 January 2022.
- National Standards for Blood Centres and Blood Transfusion Services, 2nd ed., Ministry of Health & Family Welfare, Government of India, 2022.
- Roberts N, James S, Delaney M, Fitzmaurice C. The global need and availability of blood products: a modelling study. Lancet Haematol 2019;6:e606–15.
- Tiwari AK, Aggarwal G, Dara RC, Arora D, Gupta GK, Raina V. First Indian study to establish safety of immediate-spin crossmatch for red blood cell transfusion in antibody screen-negative recipients. Asian J Transfus Sci 2017;11:40–4.
- Pathak S, Chandrashekhar M, Wankhede GR. Type and screen policy in the blood bank: is AHG cross-match still required? A study at a multispecialty corporate hospital in India. Asian J Transfus Sci 2011;5:153–6.
- Agrawal A. Type and screen policy: is there any compromise on blood safety? Transfus Apher Sci 2014;50:271–3.
- Chaudhary R, Agarwal N. Safety of type and screen method compared to conventional antiglobulin crossmatch procedures for compatibility testing in Indian setting. Asian J Transfus Sci 2011;5:157–9.
- Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977;17:163–8.
- Bruggeman CW, Nagelkerke SQ, Lau W, et al. Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. Blood Adv 2020;4:3416–26.
- Bachofner A, Rüfli T, Holbro A, et al. The remarkable journey of a low-frequency alloantibody. Transfus Med Hemother 2019;46:384–5.
- Mintz PD, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test. Transfusion 1982;22:107–10.
- Garratty G. Abbreviated pretransfusion testing. Transfusion 1986;26:217–9.
- Oberman HA, Barnes BA, Steiner EA. Role of the crossmatch in testing for serologic incompatibility. Transfusion 1982;22: 12–6.
- Pandey P, Setya D, Srivastava R, Singh MK. A prospective, observational study for optimization of antibody screening in pretransfusion compatibility testing. Immunohematology 2020;36:19–28.
- Datta SS, Mukherjee S, Talukder B, Bhattacharya P, Mukherjee K. Frequency of red cell alloimmunization and autoimmunization in thalassemia patients: a report from Eastern India. Adv Hematol 2015;2015:610931.
- Shastry S, Chenna D, Basavarajegowda A, Das S, Chaudhary RK. Red blood cell alloimmunization among recipients of blood transfusion in India: a systematic review and meta-analysis. Vox Sang 2022;117:1057–69. doi: 10.1111/vox.13296.
- Basu D, Datta SS, Montemayor C, Bhattacharya P, Mukharjee K, Flegel WA. ABO, Rhesus, and Kell antigens, alleles, and haplotypes in West Bengal, India. Transfus Med Hemother 2018;45:62–6.
- Perkins RP. The significance of the anti-Lewis antibodies in pregnancy. Am J Obstet Gynecol 1970;107:28–32.
- Das S, Shastry S, Rai L, Baliga PB. Frequency and clinical significance of red cell antibodies in pregnancy: a prospective study from India. Indian J Pathol Microbiol 2020;63:241–6.
- Aggarwal G, Tiwari AK, Arora D, et al. Advantages of type and screen policy: perspective from a developing country! Asian J Transfus Sci 2018;12:42–5.